BTG appoints Anne Thorburn to its Board as Non-Executive Director

– UK, London – BTG plc (LSE: BTG) the specialist healthcare company, today announces the appointment of Anne Thorburn as a non-executive director of the Board and member of the Audit Committee.

Anne has an extensive range of international financial management, risk, audit and M&A experience. She was Chief Financial Officer of Exova Group plc from 2009 to 2015 and previously served as Group Finance Director at British Polythene Industries PLC. Anne is a non-executive director and Chair of the Audit Committee at Diploma PLC and is a member of the Institute of Chartered Accountants in Scotland.

Garry Watts, BTG’s Chairman, commented: “We are pleased to welcome Anne to the Board. She brings significant financial and broad business experience to BTG’s Board, which will benefit the Company as we continue to implement our growth plans.”

About BTG

BTG is an international specialist healthcare company that is developing and commercializing products targeting acute care, cancer and vascular diseases. The company has diversified revenues from sales of its own marketed products and from royalties on partnered products, and is seeking to acquire new programs and products to develop and market to specialist physicians.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.